Novel antibiotics: DEINOVE signs an agreement with the Institut Pasteur to explore the potential of new targeted strains

    NEXT STORY
    OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
    PREV STORY
    Healthcare Chatbots Market Worth USD 316.85 Mn by 2023 at 21.10% CAGR | Advancing AI to Drive Healthcare Chatbots Industry
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Novel antibiotics: DEINOVE signs an agreement with the Institut Pasteur to explore the potential of new targeted strains

    NEXT STORY
    OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
    PREV STORY
    Healthcare Chatbots Market Worth USD 316.85 Mn by 2023 at 21.10% CAGR | Advancing AI to Drive Healthcare Chatbots Industry
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    ZIOPHARM Oncology to Participate at Upcoming CAR-TCR Summit

    BOSTON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused ...

    author_avatar
    NASDAQ Market News

    Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights

    Company reported net ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) sales of $7.0 million in ...

    author_avatar
    NASDAQ Market News